Gene · 3148
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological therapies for premature ovarian insufficiency: what is the evidence? | Front Reprod Health | 2023 | 37744287 | PubTator, text mining | PubMed |
| Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression. | Mol Ther Nucleic Acids | 2023 | 37744174 | PubTator, text mining | PubMed |
| A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data. | Ann Med | 2023 | 37729607 | PubTator, text mining | PubMed |
| New Insights into the Role of HMGB2 in ST-Segment Elevation Myocardial Infarction. | Int J Gen Med | 2023 | 37727529 | PubTator, text mining | PubMed |
| Identifying genetic regulatory variants that affect transcription factor activity. | Cell Genom | 2023 | 37719147 | PubTator, text mining | PubMed |
| Correlation of serum HMGB1 and HMGB2 levels with clinical symptoms in allergic rhinitis children. | Medicine (Baltimore) | 2023 | 37713866 | PubTator, text mining | PubMed |
| Transcriptomic approaches for identifying potential transmission blocking vaccine candidates in Plasmodium falciparum: a review of current knowledge and future directions. | 3 Biotech | 2023 | 37711230 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer. | Nat Commun | 2023 | 37704621 | PubTator, text mining | PubMed |
| Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses. | PLoS Pathog | 2023 | 37703278 | PubTator, text mining | PubMed |
| HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases. | Mol Med | 2023 | 37667233 | PubTator, text mining | PubMed |
| Probing the communication patterns of different chondrocyte subtypes in osteoarthritis at the single cell level using pattern recognition and manifold learning. | Sci Rep | 2023 | 37660146 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML. | Genome Biol | 2023 | 37653425 | PubTator, text mining | PubMed |
| Urinary and serum levels of high mobility group box 1. | Pract Lab Med | 2023 | 37649540 | PubTator, text mining | PubMed |
| Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination. | Hum Vaccin Immunother | 2023 | 37614152 | PubTator, text mining | PubMed |
| Impaired Plakophilin-2 in obesity breaks cell cycle dynamics to breed adipocyte senescence. | Nat Commun | 2023 | 37607954 | PubTator, text mining | PubMed |
| Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha. | Front Immunol | 2023 | 37588598 | PubTator, text mining | PubMed |
| Regulation of DNA damage and transcriptional output in the vasculature through a cytoglobin-HMGB2 axis. | Redox Biol | 2023 | 37573836 | PubTator, text mining | PubMed |
| The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33. | Int J Mol Sci | 2023 | 37569519 | PubTator, text mining | PubMed |
| Recent Advances in Breast Cancer Research. | Int J Mol Sci | 2023 | 37569366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3148/papers?page=11